In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
Business
·
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
CN
CitrixNews Staff
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Business
How Dollywood Captured the Essence of Dolly Parton
Her idea to create a “fantasy city” that celebrated her home region turned into a billion-dollar attraction that maintai...
CitrixNews Staff
·
1 hour ago
Business
The London stock market dodged a bullet with Shein | Nils Pratley
China’s fashion giant will list in Hong Kong with a shrunken price tag – and big questions over its business modelIn a p...
CitrixNews Staff
·
2 hours ago
Business
Trump Administration Wants Billion-Dollar Businesses to Qualify as ‘Small’
Higher revenue and employee limits for small businesses that get federal contracts and loans could disadvantage the smal...
CitrixNews Staff
·
2 hours ago
Business
Will Trump's latest beef plan make your hamburger cheaper? Not much, experts say
Food Will Trump's latest beef plan make your hamburger cheaper? Not much, experts say August 26, 202610:58 AM ET By&n...
CitrixNews Staff
·
3 hours ago